Can BCG vaccination at first health-facility contact reduce early infant mortality? Study protocol for a cluster-randomised trial (CS-BCG)
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Forlagets udgivne version, 315 KB, PDF-dokument
Increasing evidence suggests that the BCG vaccine has non-specific effects, altering the susceptibility to non-tuberculous infections. Thus, early BCG vaccination may reduce mortality. BCG is recommended at birth but is often delayed. Vaccination opportunities are missed due to multidose vials not being opened for a few children. We will assess the effect of making BCG available at the first health-facility contact on early infant mortality and morbidity in a rural setting in Guinea-Bissau
Originalsprog | Engelsk |
---|---|
Artikelnummer | 063872 |
Tidsskrift | BMJ Open |
Vol/bind | 12 |
Udgave nummer | 11 |
Antal sider | 7 |
ISSN | 2044-6055 |
DOI | |
Status | Udgivet - 2022 |
ID: 330460406